These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 16326223)

  • 41. New horizons in erectile and endothelial dysfunction research and therapies.
    Giuliano F
    Int J Impot Res; 2008 Dec; 20 Suppl 2():S2-8. PubMed ID: 19002115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The erectile-endothelial dysfunction nexus: new opportunities for cardiovascular risk prevention.
    Watts GF; Chew KK; Stuckey BG
    Nat Clin Pract Cardiovasc Med; 2007 May; 4(5):263-73. PubMed ID: 17457350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Relationship between erectile dysfunction and cardiovascular disease].
    Roumeguère T; Schulman C
    Rev Med Brux; 2004 Dec; 25(6):507-11. PubMed ID: 15688889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is erectile dysfunction a sentinel symptom for cardiovascular autonomic neuropathy in patients with type 2 diabetes?
    Debono M; Cachia E; Cassar A; Calleja N; Mallia M; Vassallo J
    Andrologia; 2008 Feb; 40(1):1-6. PubMed ID: 18211294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The safety of 5-phosphodiesterase inhibitors in the treatment of erectile dysfunction in patients with cardiovascular disease].
    Bryniarski L; Rzepecki M; Klocek M; Wyczołkowski M
    Przegl Lek; 2009; 66(4):192-7. PubMed ID: 19708509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Erectile dysfunction is a marker for cardiovascular disease: results of the minority health institute expert advisory panel.
    Billups KL; Bank AJ; Padma-Nathan H; Katz S; Williams R
    J Sex Med; 2005 Jan; 2(1):40-50; discussion 50-2. PubMed ID: 16422903
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of endothelial dysfunction in the pathophysiology of erectile dysfunction in diabetes and in determining response to treatment.
    Pegge NC; Twomey AM; Vaughton K; Gravenor MB; Ramsey MW; Price DE
    Diabet Med; 2006 Aug; 23(8):873-8. PubMed ID: 16911625
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Erectile dysfunction and cardiovascular risk factors.
    Kloner RA
    Urol Clin North Am; 2005 Nov; 32(4):397-402, v. PubMed ID: 16291032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient.
    Montorsi P; Ravagnani PM; Galli S; Salonia A; Briganti A; Werba JP; Montorsi F
    Eur Urol; 2006 Oct; 50(4):721-31. PubMed ID: 16901623
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diabetic erectile dysfunction--an indicator of generalised endothelial function per se?
    Browne DL; Meeking DR; Allard S; Munday LJ; Shaw KM; Cummings MH
    Int J Clin Pract; 2006 Oct; 60(10):1323-6. PubMed ID: 16981979
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Smoking causes erectile dysfunction through vascular disease.
    Shiri R; Häkkinen J; Koskimäki J; Tammela TL; Auvinen A; Hakama M
    Urology; 2006 Dec; 68(6):1318-22. PubMed ID: 17141835
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ["Penis angina" or the current revolution in erectile dysfunction (ED)].
    Bondil P; Delmas V
    Prog Urol; 2005 Dec; 15(6):1030-4. PubMed ID: 16429648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyperhomocysteinemia is a risk factor for erectile dysfunction in men with adult-onset diabetes mellitus.
    Al-Hunayan A; Thalib L; Kehinde EO; Asfar S
    Urology; 2008 May; 71(5):897-900. PubMed ID: 18455630
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Erectile dysfunction: a harbinger or consequence: does its detection lead to a window of curability?
    Miner MM
    J Androl; 2011; 32(2):125-34. PubMed ID: 20864648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How to save a life during a clinic visit for erectile dysfunction by modifying cardiovascular risk factors.
    Schwartz BG; Kloner RA
    Int J Impot Res; 2009; 21(6):327-35. PubMed ID: 19693019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Diagnosis of arteriogenic erectile dysfunction at the level of primary health care].
    Mazo EB; Gamidov SI; Andranovich SV; Iremashvili VV
    Ter Arkh; 2006; 78(10):51-6. PubMed ID: 17180939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Medical implications of erectile dysfunction.
    Berookhim BM; Bar-Chama N
    Med Clin North Am; 2011 Jan; 95(1):213-21. PubMed ID: 21095424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes.
    Kapoor D; Clarke S; Channer KS; Jones TH
    Int J Androl; 2007 Dec; 30(6):500-7. PubMed ID: 18028199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular risk factors determine erectile and arterial function response to sildenafil.
    Solomon H; Wierzbicki AS; Lumb PJ; Lambert-Hammill M; Jackson G
    Am J Hypertens; 2006 Sep; 19(9):915-9. PubMed ID: 16942933
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease.
    Ravipati G; McClung JA; Aronow WS; Peterson SJ; Frishman WH
    Cardiol Rev; 2007; 15(2):76-86. PubMed ID: 17303994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.